Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 89 K85 K88 K102 K77 K129 K 396 K Research & development —————— — Operating income -63 K-60 K-63 K-79 K-51 K-101 K -294 K Non-Operating Income, Total 43 K42 K43 K91 K37 K35 K 206 K Interest expense, net of interest capitalized —————— — Non-Operating Income, excl. Interest Expenses 43 K42 K43 K91 K37 K35 K 206 K Unusual income/expense —————— — Pretax income -20 K-18 K-20 K12 K-14 K136 K 114 K Equity in earnings —————— — Taxes ———-148 K—— — Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations -20 K-18 K-20 K12 K-14 K-66 K -88 K Discontinued operations —————— — Net income -20 K-18 K-20 K12 K-14 K-66 K -88 K Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders -20 K-18 K-20 K12 K-14 K66 K 44 K Basic earnings per share (Basic EPS) -0.010-0.010.01-0.01-0.01 -0.02 Diluted earnings per share (Diluted EPS) -0.010-0.010.01-0.01-0.01 -0.02 Average basic shares outstanding 5 1325 1325 1325 1325 1325 132 — Diluted shares outstanding 5 1325 1325 1325 1325 1325 132 — EBITDA -60 K-56 K-60 K-75 K-48 K-97 K -280 K EBIT -63 K-60 K-63 K-79 K-51 K-101 K -294 K Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) 3 0004 0003 0004 0003 0003 000 13 K